AZANTA DANMARK A/S
CVR 25260279 · Public limited company (A/S) · Active · Low risk
AZANTA DANMARK A/S is a Public limited company (A/S), founded on , based in Valby. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.1 times the average for Danish companies. 20 annual reports have been published, of which 5 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 342.2m and a net result of DKK 28.7m.
Bankruptcy risk for AZANTA DANMARK A/S
0.1 × the average (1.41%) · higher risk than 38% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 25260279
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (26 years)
- Address
- Kirsten Walthers Vej 8A, 2.
2500 Valby - Municipality
- København
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 2.1m
- Employees
- 2 (2018)
- Auditor
- EY Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 6 of 26 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 94.8% |
| Current ratio | – |
| Moves (last 2 years) | 0 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 4 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Revenue | DKK 24.5m | DKK 22.7m |
| Gross profit | DKK 20.3m | DKK 15.9m |
| Net profit | DKK 28.7m | DKK 21.6m |
| Equity | DKK 342.2m | DKK 313.5m |
| Total assets | DKK 360.9m | DKK 336.8m |
| Cash | DKK 543k | – |
| Short-term debt | DKK 18.7m | – |
| Avg. employees | 2 | – |
Latest annual report: Reporting class B · auditor's statement: Independent Auditor’s Report · EY Godkendt Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 212 | Late | |
| 1 Jan 2024 – 31 Dec 2024 | 197 | Late | |
| 1 Jan 2023 – 31 Dec 2023 | 192 | Late | |
| 1 Jan 2022 – 31 Dec 2022 | 219 | Late | |
| 1 Jan 2021 – 31 Dec 2021 | 196 | Late | |
| 1 Jan 2020 – 31 Dec 2020 | 183 | ||
| 1 Jan 2019 – 31 Dec 2019 | 135 | ||
| 1 Jan 2018 – 31 Dec 2018 | 121 | ||
| 1 Jan 2017 – 31 Dec 2017 | 143 | ||
| 1 Jan 2016 – 31 Dec 2016 | 111 | ||
| 1 Jan 2015 – 31 Dec 2015 | 103 | ||
| 1 Jan 2014 – 31 Dec 2014 | 181 | ||
| 1 Jan 2013 – 31 Dec 2013 | 152 | ||
| 1 Jan 2012 – 31 Dec 2012 | 157 | ||
| 1 Jan 2011 – 31 Dec 2011 | 136 | ||
| 1 Jan 2010 – 31 Dec 2010 | 90 | ||
| 1 Jan 2009 – 31 Dec 2009 | 153 | ||
| 1 Jan 2008 – 31 Dec 2008 | 119 | ||
| 1 Jan 2007 – 31 Dec 2007 | 155 | ||
| 1 Jan 2006 – 31 Dec 2006 | 151 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Per Bo Pedersen Fischer | ||
| CEO | Richard Henry Poulsen | ||
| Board | Erik Niklas Eriksson | Current | |
| Board | Laura Elizabeth Barrell | Current | |
| Board | Ina Høydal Helle | Current | |
| Board | Jens Christian Jensenius | ||
| Board | Per Bo Pedersen Fischer | ||
| Board | Steffen Thiel | ||
| Board | Thomas Feldthus | ||
| Board | Ulrik Spork | ||
| Board | Torsten Erik Rasmussen | ||
| Board | Steen Helde Hemmingsen | ||
| Board | Claus Henrik Berner Møller | ||
| Board | R. Alan B Ezekowitz | ||
| Board | Peter Finsel Bisgaard | ||
| Board | Birgitte Holck-Andersen | ||
| Board | Per Otto Hyland | ||
| Board | James Peter Arthur Benzon | ||
| Board | James Peter Arthur Benson | ||
| Board | Gudmund Tyge Korsgaard | ||
| Board | Jan Andersen | ||
| Board | Bo Kruse | ||
| Board | Claus Juan Møller-San Pedro | ||
| Board | Hanne Damgaard Jensen | ||
| Board | Lars Aaen | ||
| Board | Hanne Damgaard Jensen | ||
| Board | Helle Heidensleben | ||
| Board | Jens Munch-Hansen | ||
| Board | David Carl Christian von Kauffmann | ||
| Board | Christian Gunni Pedersen | ||
| Board | Christian Gunni Pedersen | ||
| Board | David Carl Christian von Kauffmann | ||
| Board | Tara Bussey | ||
| Board | Kenneth Eric Scrimgeour | ||
| Board | Paul John Ruelle | ||
| Board | Erik Niklas Eriksson | ||
| Board | Erik Niklas Eriksson | ||
| Board | Jeremy John Cuffe | ||
| Board | Kenneth Andrew MacRitchie | ||
| Board | Kenneth Andrew MacRitchie | ||
| Board | Marie Sophie Romann | ||
| Board | Michael Lange | ||
| Board | Roderik Henricus Catharinus | ||
| Board | Ina Høydal Helle | ||
| Owner (100%) | AZANTA A/S | Current | |
| Auditor | EY Godkendt Revisionspartnerselskab | Current | |
| Auditor | Revisionsfirmaet Ankjær-Jensen I/S statsautoriserede revisorer | ||
| Auditor | EY Danmark A/S | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | EY Godkendt Revisionspartnerselskab | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Jens Christian Jensenius | Current | |
| Founder | Per Bo Pedersen Fischer | Current | |
| Founder | Steffen Thiel | Current | |
| Founder | R. Alan B Ezekowitz | Current |
The CEOs' other companies
Per Bo Pedersen Fischer – 6 other companies, of which 2 bankrupt
- Holdingselskabet af 23. december 2021 A/S Bankrupt 12 Jan 2022
- Selskabet af 23. december 2021 A/S Bankrupt 12 Jan 2022
- FGP IMPORT ApS Opløst
- FISCHER BIOCONSULT ApS Active
- HELION BIOTECH ApS Active
- Proxi Biotech ApS Active
Richard Henry Poulsen – 2 other companies
- AZANTA A/S Active
- Afyx Therapeutics A/S Active
Address history (4 moves)
| Kirsten Walthers Vej 8A, 2., 2500 Valby | |
| Gearhalsvej 1, st., 2500 Valby | |
| Tranegårdsvej 20, 2900 Hellerup | |
| Fruebjergvej 3, 2100 København Ø | |
| Ribegade 20, 2. th, 2100 København Ø |
Former names
| AZANTA DANMARK A/S | – now |
| NATIMMUNE A/S | – |
| NATIMMUNE ApS | – |
Employees per year
Other companies at the same address
- AZANTA A/S Active
- Hero Denmark ApS Active
- NORGINE DANMARK A/S Active
- Selskabet af 25.03.2020 A/S Opløst
Similar companies in København
- CARLSBERG A/S København V
- CuraVision ApS København V
- Launch Bioindustries ApS København Ø
- RheumaLogics ApS København Ø
- Vitibiotech ApS København N
- Pyovita ApS Hellerup
- ArcanaBio ApS København N
- OvartiX ApS København N
- Keystone Consulting ApS København SV
- KPL ApS København N
- Alveus Therapeutics ApS København K
- Cambiotics ApS København N
Questions and answers about AZANTA DANMARK A/S
Has AZANTA DANMARK A/S gone bankrupt?
No, AZANTA DANMARK A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of AZANTA DANMARK A/S?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.1 times the average for Danish companies.
Who is the auditor of AZANTA DANMARK A/S?
AZANTA DANMARK A/S most recently used EY Godkendt Revisionspartnerselskab.
When was AZANTA DANMARK A/S founded?
AZANTA DANMARK A/S was founded on 17 March 2000.
What is the equity of AZANTA DANMARK A/S?
Equity was DKK 342.2m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.